# Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin

> **NCT01785615** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Rochester** · enrollment: 116 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Atorvastatin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01785615
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2011-12
- **Final completion:** 2013-05
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2017-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01785615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01785615, "Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01785615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*